Henan Jinyuan Hydrogenated Chemicals (2502) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
16 Oct, 2026Executive summary
Revenue rose 3.4% YoY to RMB2,330.2m, while profit attributable to shareholders fell to RMB54.9m from RMB138.2m as gross margin compressed.
Capacity expansion in hydrogenated benzene chemicals and new hydrogen stations advanced the shift toward hydrogen energy.
Financial highlights
Revenue was RMB2,330.2m vs RMB2,254.5m; gross profit declined to RMB148.8m from RMB287.7m.
Profit before tax fell to RMB98.9m from RMB233.5m; net income was RMB82.3m vs RMB194.1m, and owners’ attributable profit was RMB54.9m vs RMB138.2m.
Basic EPS was RMB0.09 vs RMB0.26; gross margin declined to 6.4% from 12.8%.
Finance costs decreased to RMB6.1m from RMB8.0m, while selling and distribution expenses increased to RMB18.4m from RMB15.4m.
Outlook and guidance
Plans include building 15 hydrogen-refuelling stations in Zhengzhou over 3–5 years; in 2024, stations or integrated energy stations are planned in Jiaozuo and Zhengzhou.
Hydrogen strategy targets fuel-cell vehicles and a broader chain covering production, transport, storage, refuelling and use; 2024 investments are to use internal resources and listing proceeds.
Continued priorities include improving chemicals production efficiency, safety and environmental protection, and improving LNG production stability while lowering costs.
Latest events from Henan Jinyuan Hydrogenated Chemicals
- Revenue expanded, but margin pressure drove an owners’ loss and weaker returns.2502
H2 2024 - Revenue rose 48.9%, but input-cost pressure cut margins and H1 profit to RMB44.9m.2502
H1 2024 - Lower chemical prices compressed margins, driving an H1 net loss despite hydrogen-station growth.2502
H1 2025 - Lower chemical prices and energy margins drove a return to loss despite stronger operating cash flow.2502
H2 2025 - Improved margins restored H1 profitability despite a major receivable impairment and weaker trading sales.2502
H1 2026